title: [Factors associated with antiretroviaral treatment observance at Point "G" hospital].
abstract: OBJECTIVE
  To study the factors associated with the observance of treatment ARV among patients followed in hospital medium to Bamako.
  
  
  METHODS
  Inquire longitudinal with collection of the data near the patients followed in one of the three greater sites of assumption of responsibility of the people reached with the VIH/SIDA to Mali. The people were regarded as observing if they took at least 95% of their treatment the moment of the investigation.
  
  
  RESULTS
  The patients were between 1 and 40 months of treatment the moment of the investigation. The average age was 44 years with extremes going from 19 to 70 years. Association Lamivudine +Stavudine + Nevirapine (triomune) was the most prescribed antiretroviral therapy (34.2%). The bad observance was noted at 58.5% of the patients. The principal causes of bad observance were: the lapse of memory 47.5% (96/202) and difficulties of access to the hospital 34.6% (70/202). The changes of molecules were due primarily to the out-of-stock condition, and the side effects. The factor associated with a good observance was the assistance of the patient by a member of the family informed of seropositivity.
  
  
  CONCLUSIONS
  The interest of HIV patient to his treatment could contribute to enhance antiretroviral Adherence particularly in this hospital and generally in Mali.
authors.affiliation: Faculté de Médecine, de Pharmacie et d’odontostomatologie, Hôpital du point G, Bamako. alabmai@yahoo.fr
authors.forename: A A
authors.initials: AA
authors.lastname: Oumar
authors.forename: S
authors.initials: S
authors.lastname: Dao
authors.forename: A
authors.initials: A
authors.lastname: Diamoutene
authors.forename: S
authors.initials: S
authors.lastname: Coulibaly
authors.forename: B
authors.initials: B
authors.lastname: Koumare
authors.forename: I I
authors.initials: II
authors.lastname: Maiga
authors.forename: E
authors.initials: E
authors.lastname: Mariko
mesh_terms: D000328:Adult; D000368:Aged; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006761:Hospitals; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D055815:Young Adult; D016903:Drug Monitoring
chemical_list: D044966:Anti-Retroviral Agents